Patents Assigned to KUNMING SHENGHUO PHARMACEUTICAL (GROUP) CO., LTD.
  • Patent number: 9526713
    Abstract: Disclosed are uses of drugs for treating thrombocytopenia, in particular the use of dencichine in preparation of drugs for treating thrombocytopenia. By adding pharmaceutically acceptable conventional adjuvant material, dencichine can be prepared into an oral preparation or an injection. A pharmacodynamic trial shows that the dencichine can effectively inhibit the thrombocytopenia caused by chemotherapy drugs, and treat thrombocytopenic purpura with obvious curative effect and low toxic side effects.
    Type: Grant
    Filed: May 24, 2013
    Date of Patent: December 27, 2016
    Assignee: KUNMING SHENGHUO PHARMACEUTICAL (GROUP) CO., LTD.
    Inventors: Guihua Lan, Feng Lan, Xiaobo Sun
  • Publication number: 20160089351
    Abstract: Disclosed are uses of drugs for treating thrombocytopenia, in particular the use of dencichine in preparation of drugs for treating thrombocytopenia. By adding pharmaceutically acceptable conventional adjuvant material, dencichine can be prepared into an oral preparation or an injection. A pharmacodynamic trial shows that the dencichine can effectively inhibit the thrombocytopenia caused by chemotherapy drugs, and treat thrombocytopenic purpura with obvious curative effect and low toxic side effects.
    Type: Application
    Filed: May 24, 2013
    Publication date: March 31, 2016
    Applicant: KUNMING SHENGHUO PHARMACEUTICAL (GROUP) CO., LTD.
    Inventors: Guihua LAN, Feng LAN, Xiaobo SUN